Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPA for Knee Osteoarthritis
NCT04657926Phase 2Completed
- Sponsor
- AKL Research & Development Limited
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoarthritis (OA) comparing APPA with Placebo (2 arms). Primary endpoint: WOMAC pain score at 28 days. Started Sep 2020; status: completed.
02
Drugs
APPA
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04657926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04657926.